Compassionate use of cefiderocol for VIM metallo-β-lactamase-producing Pseudomonas aeruginosa infection in a toddler with Burkitt lymphoma

J Glob Antimicrob Resist. 2021 Sep:26:91-92. doi: 10.1016/j.jgar.2021.04.025. Epub 2021 May 26.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Burkitt Lymphoma* / drug therapy
  • Cefiderocol
  • Cephalosporins
  • Child, Preschool
  • Compassionate Use Trials
  • Humans
  • Pseudomonas Infections* / drug therapy
  • beta-Lactamases / genetics

Substances

  • Cephalosporins
  • beta-Lactamases